HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 927012Generated: October 31, 2026
Triethylamine → 4-{2-[5-Acetyl-3,6-dimethyl-2-oxo-1-(3-trifluoromethyl-phenyl)-1,2,3,4-tetrahydro-pyrimidin-4-yl]-5-cyano-benzoylamino}-piperidine-1-carboxylic acid tert-butyl ester
https://huagongshe.com/reaction/927012
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| Reactant | US9290457, Intermediate 6 | HCID 118691679 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 4-{2-[5-Acetyl-3,6-dimethyl-2-oxo-1-(3-trifluoromethyl-phenyl)-1,2,3,4-tetrahydro-pyrimidin-4-yl]-5-cyano-benzoylamino}-piperidine-1-carboxylic acid tert-butyl ester | HCID 118691690 | — |
Reaction Steps
To a solution of 2-[5-acetyl-3,6-dimethyl-2-oxo-1-(3-trifluoromethyl-phenyl)-1,2,3,4-tetrahydro-pyrimidin-4-yl]-5-cyano-benzoic acid (intermediate 6, 40.0 mg, 0.09 mmol) in N,N-dimethylformamide (1 mL) triethylamine (25.0 μL, 0.18 mmol) is added and stirred at room temperature for 5 min. Then O-(7-azabonzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (34.9 mg, 0.09 mmol) is added and stirred for 15 min. A solution of tert-butyl 1-piperazinecarboxylate (24.4 mg, 0.13 mmol) and triethylamine (25.0 μL, 0.18 mmol) in N,N-dimethylformamide (1 mL) is added and stirred at room temperature for 72 h. The reaction mixture is purified by reversed phase HPLC. ESI mass spectrum [M-Boc+H]+=526; Retention time HPLC: 1.16 min (HPLC method Z018_S04).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09290457B2 |
|---|
| Source dataset | uspto-grants-2016_03 |
|---|
| ORD ID | ord-2330a4cd6e074a079073d867ee8dcf81 |
|---|
| Source note | uspto-grants-2016_03 |
|---|